StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.74+0.05 (+1.86%)

Close on Nov 19, 2026Market cap $117.68MP/E –Yield –

Pulmonx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Pulmonx's gross profit for the twelve months ending Jun 30, 2026 was $67.38M, up 1.8% year over year. For fiscal 2025 it was $67.14M, up 8.3% from the year before. The highest annual figure on record is $67.14M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$67.14M+8.3%
FY2024Dec 31, 2024$62.00M+22.2%
FY2023Dec 31, 2023$50.75M+27.3%
FY2022Dec 31, 2022$39.87M+11.9%
FY2021Dec 31, 2021$35.63M+68.1%
FY2020Dec 31, 2020$21.20M-5.4%
FY2019Dec 31, 2019$22.41M+82.4%
FY2018Dec 31, 2018$12.29M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.74M+3.1%
Q1 FY2026Mar 31, 2026$16.04M-1.8%
Q4 FY2025Dec 31, 2025$17.54M-0.3%
Q3 FY2025Sep 30, 2025$16.05M+6.8%
Q2 FY2025Jun 30, 2025$17.20M+12.4%
Q1 FY2025Mar 31, 2025$16.34M+16.1%
Q4 FY2024Dec 31, 2024$17.59M+22.2%
Q3 FY2024Sep 30, 2024$15.03M+15.3%
Q2 FY2024Jun 30, 2024$15.31M+20.2%
Q1 FY2024Mar 31, 2024$14.08M+32.9%
Q4 FY2023Dec 31, 2023$14.40M+28.8%
Q3 FY2023Sep 30, 2023$13.03M+28.3%
Q2 FY2023Jun 30, 2023$12.73M+22.2%
Q1 FY2023Mar 31, 2023$10.59M+30.6%
Q4 FY2022Dec 31, 2022$11.18M+9.1%
Q3 FY2022Sep 30, 2022$10.15M+4.2%
Q2 FY2022Jun 30, 2022$10.42M+15.4%
Q1 FY2022Mar 31, 2022$8.11M+22.7%
Q4 FY2021Dec 31, 2021$10.25M+44.8%
Q3 FY2021Sep 30, 2021$9.74M+30.5%
Q2 FY2021Jun 30, 2021$9.03M+792.2%
Q1 FY2021Mar 31, 2021$6.61M+17.0%
Q4 FY2020Dec 31, 2020$7.08M-3.5%
Q3 FY2020Sep 30, 2020$7.46M+16.5%
Q2 FY2020Jun 30, 2020$1.01M-79.6%
Q1 FY2020Mar 31, 2020$5.65M+52.0%
Q4 FY2019Dec 31, 2019$7.34M–
Q3 FY2019Sep 30, 2019$6.41M–
Q2 FY2019Jun 30, 2019$4.95M–
Q1 FY2019Mar 31, 2019$3.72M–

More Pulmonx figures

See a number that looks wrong?